SCHEMBL8286148

SCHEMBL8286148

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2cc(Cc3ccccc3)ncc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.36
MAT2A P31153 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
CCND2 P30279 2/20 0.36
CCND3 P30281 2/20 0.36
EGLN1 Q9GZT9 1/20 0.35
PDE11A Q9HCR9 1/20 0.35
MAPK8 P45983 2/20 0.34
MAPK9 P45984 2/20 0.34
HTR2B P41595 1/20 0.33
FEN1 P39748 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287455 0.91 MAT2A (0.36) GSK3BMAT2ANPC1RAB9ACDK4
SCHEMBL8286574 0.88 MAT2A (0.39) GSK3BMAT2ACDK4CCND1CCND2
SCHEMBL8287617 0.87 GSK3B (0.37) GSK3BMAT2ACDK4CCND1CCND2
SCHEMBL8286150 0.87 GSK3B (0.39) GSK3BMAT2ACDK4CCND1CCND2
SCHEMBL8286162 0.87 GSK3B (0.37) GSK3BMAT2ACDK4CCND1CCND2
SCHEMBL8286453 0.84 GSK3B (0.35) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287945 0.84 S1PR1 (0.39) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287498 0.84 GSK3B (0.37) GSK3BMAT2ACDK4CCND1CCND2
SCHEMBL8287283 0.84 PDE11A (0.34) GSK3BMAT2ACDK4CCND1CCND2
SCHEMBL8287515 0.84 BCL6 (0.40) GSK3BMAT2ANPC1RAB9ACDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed